Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I interferon and cancer
Peter Holíček, Emma Guilbaud, Vanessa Klapp, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 115-127
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors
Guohao Li, Xiangqian Zhao, Zuda Zheng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 17
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 11
Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 19-39
Closed Access | Times Cited: 7
Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy
Hang Zhou, Wenjun Wang, Hairong Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling
Matilde Monti, Giorgia Ferrari, Luisa Gazzurelli, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
GBM immunotherapy: Exploring molecular and clinical frontiers
Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, et al.
Life Sciences (2024) Vol. 356, pp. 123018-123018
Closed Access | Times Cited: 4
ORMDL3 restrains type-I interferon signaling and anti-tumor immunity by promoting RIG-I degradation
Qi Zeng, Yao Chen, Shimeng Zhang, et al.
(2025)
Open Access
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Interferon-stimulated gene IFI27 as a multifaceted candidate target in precision medicine
Maryam Shojaei, Anthony S. McLean
Trends in Immunology (2025)
Open Access
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma
Jiwoong Yu, Hyeonju Ahn, Kyung Yeon Han, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Type I interferon protects against bone loss in periodontitis by mitigating an interleukin (IL)-17-neutrophil axis
Jinmei Zhang, Qiong Ding, Angela X. Wang, et al.
Life Sciences (2025), pp. 123559-123559
Open Access
Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death
D. H. Zhang, Songze Song, Jing Lin, et al.
Developmental Cell (2025)
Closed Access
ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation
Qi Zeng, Yao Chen, Shimeng Zhang, et al.
eLife (2025) Vol. 13
Open Access
Environment-responsive dendrobium polysaccharide hydrogel embedding manganese microsphere as a post-operative adjuvant to boost cascaded immune cycle against melanoma
Nan Gao, Yiran Huang, Shisuo Jing, et al.
Theranostics (2024) Vol. 14, Iss. 10, pp. 3810-3826
Open Access | Times Cited: 4
TAGLN2 induces resistance signature ISGs by activating AKT-YBX1 signal with dual pathways and mediates the IFN-related DNA damage resistance in gastric cancer
Huiqin Zhuo, Jingjing Hou, Zhijun Hong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 4
The danger theory of immunity revisited
Guido Kroemer, Léa Montégut, Oliver Kepp, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 912-928
Closed Access | Times Cited: 4
Parkin activates innate immunity and promotes anti-tumor immune responses
Michela Perego, Minjeong Yeon, Ekta Agarwal, et al.
Journal of Clinical Investigation (2024)
Open Access | Times Cited: 3
Immunological signatures from irradiated cancer-associated fibroblasts
Rodrigo Berzaghi, Kristian Gundersen, Brede Dille Pedersen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
CNS disease associated with enhanced type I interferon signalling
Yanick J. Crow
The Lancet Neurology (2024) Vol. 23, Iss. 11, pp. 1158-1168
Closed Access | Times Cited: 3
The Role of the Microbiome and of Radiotherapy-Derived Metabolites in Breast Cancer
Lourdes Herrera‐Quintana, Héctor Vázquez‐Lorente, Rafael Cardoso Maciel Costa Silva, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3671-3671
Open Access | Times Cited: 3
Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis
Yuki Minayoshi, Hitoshi Maeda, Keisuke Hamasaki, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 260-260
Open Access | Times Cited: 2
Epigenetic control of immunoevasion in cancer stem cells
Claudia Galassi, Manel Esteller, Ilio Vitale, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 2
Lactate inhibits interferon-α response in ovarian cancer by inducing STAT1 ubiquitin degradation
Xinhuai Dong, Can Lin, Lin Xu, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111099-111099
Closed Access | Times Cited: 4
Global RNA Interaction and Transcriptome Profiles Demonstrate the Potential Anti-Oncogenic Targets and Pathways of RBM6 in HeLa Cells
Ping Peng, Qingqing Yin, Wei Sun, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 9
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top